SCHEMBL8319020

SCHEMBL8319020

CN(C)C(=O)N1CCN(CCNc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1

nearest known ligand 0.59

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
EGFR P00533 15/20 0.59
ERBB2 P04626 7/20 0.59
HPGD P15428 1/20 0.59
HTT P42858 1/20 0.59
MAPT P10636 1/20 0.49
ERBB4 Q15303 3/20 0.48
BRAF P15056 4/20 0.48
CSNK2A1 P68400 1/20 0.48
JAK3 P52333 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991323 0.91 EGFR (0.61) EGFRERBB2HPGDHTTMAPT
SCHEMBL8315593 0.90 EGFR (0.59) EGFRERBB2HPGDHTTMAPT
SCHEMBL8317451 0.88 EGFR (0.69) EGFRERBB2HPGDHTTMAPT
SCHEMBL7587577 0.87 EGFR (0.57) EGFRERBB2HPGDHTTMAPT
SCHEMBL6998951 0.87 EGFR (0.56) EGFRERBB2HPGDHTTMAPT
SCHEMBL6990172 0.87 EGFR (0.59) EGFRERBB2HPGDHTTERBB4
SCHEMBL8312893 0.86 EGFR (0.64) EGFRERBB2HPGDHTTMAPT
SCHEMBL8315059 0.86 EGFR (0.60) EGFRERBB2HPGDHTTMAPT
SCHEMBL6994160 0.85 EGFR (0.76) EGFRERBB2HPGDHTTMAPT
SCHEMBL7575756 0.85 EGFR (0.55) EGFRERBB2HPGDHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779888-B1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM BOEHRINGER INGELHEIM PHARMA (DE) 1999-04-28 EP disclosed
EP-0779888-A1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1997-06-25 EP disclosed
WO-1996007657-A1 PYRIMIDO[5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1996-03-14 WO disclosed